A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Insulin Detemir (LEVEMIR)

Insulin Detemir replaces or supplements natural insulin to control blood sugar in diabetes.

First FDA approval2006-03-27
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$155.5M in CY2024 Part D spend725K claims · 275K beneficiaries · 329 plans surveyed

Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Insulin Detemir used for?

Insulin Detemir replaces or supplements natural insulin to control blood sugar in diabetes.

Is there a generic for Insulin Detemir?

No. Insulin Detemir is brand-only with no generic equivalents currently in market.

How much does my plan pay for Insulin Detemir?

NADAC pricing data not currently available for this drug.

Is Insulin Detemir on the FDA shortage list?

No. Insulin Detemir is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Insulin Analog6 alternatives in D1
01
Diluent
Brand: Sterile Diluent
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Insulin Aspart
Brand: .Insulin Aspart Protamine and Insulin Aspart
$6.94Lowest NADAC
0Generic mfrs
$704.9MCY24 Part D spend
Compare →
03
Insulin Aspart Injection
Brand: Fiasp
$6.93Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Insulin Aspart-Szjj
Brand: MERILOG
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
Insulin Aspart-Xjhz
Brand: KIRSTY
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Insulin Degludec
Brand: TRESIBA
$9.02Lowest NADAC
0Generic mfrs
$2.69BCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.